Figure 1
From: Identification of potent inhibitors of NEK7 protein using a comprehensive computational approach
(A) Depiction of the most potent inhibitors of NEK7 which were previously identified as the potent inhibitors of lipoxygenase enzyme39. (B) Binding scores and binding affinity (ki) of potent derivatives against NEK7 (C) showing the Binding scores of Dabrafenib against NEK7: reported anti-cancer drug38.
